Physician profile
Kenneth C Ball
NPI 1770593014
$3,403.34
in general payments reported to CMS, 2019-2025
21 companies · $398 in 2025
The $398 reported for 2025 was more than what 88% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $376 · 2021: $515 · 2022: $569 · 2023: $430 · 2024: $579 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,374.72 | 2019-2024 | Xarelto |
| Pfizer INC. | $541.90 | 2019-2025 | |
| Abbvie INC. | $392.39 | 2021-2025 | Avycaz, Dalvance, Teflaro |
| E.R. Squibb & Sons, L.L.C. | $241.79 | 2019-2023 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $145.72 | 2022-2024 | Dificid, Zerbaxa |
| Gilead Sciences, INC. | $139.98 | 2023-2024 | Veklury |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.69 | 2024-2025 | Xifaxan |
| Stryker Corporation | $85.93 | 2025 | Artix Mt, Clottriever Bold Catheter |
| Novartis Pharmaceuticals Corporation | $54.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $43.48 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $40.09 | 2019 | |
| Allergan, INC. | $39.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $32.47 | 2023 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $22.45 | 2025 | Austedo Xr |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.10 | 2024 | Prolia, Evenity |
| Philips North America LLC | $20.86 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.03 | 2023 | Terlivaz |
| Chiesi USA, INC. | $17.97 | 2024 | Cleviprex |
| Boston Scientific Corporation | $13.35 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.62 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.